Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 46 to 60 of 69 results for aneurysm

  1. Timing of CT head scans: What is the relative accuracy of CT head scans at different time intervals, for example 12 hours or 24 hours after symptom onset, to diagnose subarachnoid haemorrhage?

    Comes from guidance Subarachnoid haemorrhage caused by a ruptured aneurysm: diagnosis and management Number NG228 Date issued

    Research recommendation
    Published
    12 December 2022

  2. Blood pressure targets: What is the clinical and cost effectiveness of a lower blood pressure treatment target relative to the standard blood pressure treatment target for people with aneurysmal subarachnoid haemorrhage?

    Comes from guidance Subarachnoid haemorrhage caused by a ruptured aneurysm: diagnosis and management Number NG228 Date issued

    Research recommendation
    Published
    12 December 2022

  3. Antimicrobial prescribing: delafloxacin for acute bacterial skin and skin structure infections (ES32)

    Summary of the evidence on antimicrobial prescribing: delafloxacin

    Evidence summary
    Published
    5 January 2021

  4. Irreversible electroporation for treating pancreatic cancer (IPG579)

    Evidence-based recommendations on irreversible electroporation for treating pancreatic cancer. This involves inserting special needles into the tumour in the pancreas and using short electrical pulses to destroy the cancer cells.

    Interventional procedures guidance
    Published
    3 May 2017
    View recommendations

    Sections for IPG579

  5. NICE encourages research into endovascular stentgrafting of popliteal aneurysms and may review this procedure on publication of further evidence.

    NICE encourages research into endovascular stentgrafting of popliteal aneurysms and may review this procedure on publication of further...

    Research recommendation
    Published
    9 June 2015

  6. A randomised controlled trial is recommended to compare DyeVert Systems  with standard care. The aim of this research would be to address uncertainties  about whether using DyeVert Systems reduces AKI incidence and rate of renal  replacement therapy after using contrast media. This must include people with  stage 4 chronic kidney disease (with an estimated glomerular filtration rate  [eGFR] under 30 ml/min/1.73 m 2 ), who are at risk of AKI and need elective  coronary or peripheral angiography.

    procedures that use a consistent volume of contrast, such as endovascular aneurysm repair. Source guidance details Comes from guidance...

    Research recommendation
    Published
    5 November 2021

  7. Percutaneous endoscopic laser balloon pulmonary vein isolation for atrial fibrillation (IPG563)

    Evidence-based recommendations on percutaneous endoscopic laser balloon pulmonary vein isolation for atrial fibrillation in adults. This involves destroying the tissue causing atrial fibrillation using laser energy.

    Interventional procedures guidance
    Published
    27 July 2016
    View recommendations

    Sections for IPG563

  8. Negative pressure wound therapy for the open abdomen (IPG467)

    Evidence-based recommendations on negative pressure wound therapy for the open abdomen. This involves using a small pump to remove infected material, stop fluid escaping and help the wound heal.

    Interventional procedures guidance
    Published
    27 November 2013
    View recommendations

    Sections for IPG467

  9. Current evidence on the safety and efficacy of endovascular insertion of an intrasaccular wire-mesh blood-flow disruption device for intracranial aneurysms is adequate to support the use of this procedure provided that  standard arrangements   are in place for clinical governance, consent and audit.

    intrasaccular wire-mesh blood-flow disruption device for intracranial aneurysms is adequate to support the use of this procedure...

    Research recommendation
    Published
    15 November 2019

  10. Guidance and quality standards awaiting development

    Find out which guidance and quality standards are awaiting development

  11. Transcervical extracorporeal reverse flow neuroprotection for reducing the risk of stroke during carotid artery stenting (IPG561)

    Evidence-based recommendations on transcervical extracorporeal reverse flow neuroprotection for reducing the risk of stroke during carotid artery stenting in adults. This involves reversing blood flow away from the brain and filtering the blood to remove any debris.

    Interventional procedures guidance
    Published
    22 June 2016
    View recommendations

    Sections for IPG561

  12. Laser-assisted cerebral vascular anastomosis without temporary arterial occlusion (IPG252)

    Evidence-based recommendations on laser-assisted cerebral vascular anastomosis without temporary arterial occlusion. This involves using a special laser device to create a bypass without the need to temporarily interrupt the blood flow to the brain.

    Interventional procedures guidance
    Published
    27 February 2008
    View recommendations

    Sections for IPG252

  13. Chronic heart failure in adults: diagnosis and management (NG106)

    This guideline covers diagnosing and managing chronic heart failure in people aged 18 and over. It aims to improve diagnosis and treatment to increase the length and quality of life for people with heart failure.

    NICE guideline
    Last updated
    3 September 2025
    View recommendations

    Sections for NG106

  14. Prioritisation board decisions 2025

    Our centralised approach to prioritising our guidance topics ensures that we produce guidance that's relevant, timely, accessible, and has demonstrable impact.

  15. Tocilizumab for treating giant cell arteritis (TA518)

    Evidence-based recommendations on tocilizumab (RoActemra) for treating giant cell arteritis in adults.

    Technology appraisal guidance
    Published
    18 April 2018
    View recommendations

    Sections for TA518